nodes	percent_of_prediction	percent_of_DWPC	metapath
Reboxetine—Dehydration—Metformin—polycystic ovary syndrome	0.013	0.0332	CcSEcCtD
Reboxetine—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.0129	0.0329	CcSEcCtD
Reboxetine—Breast disorder—Metformin—polycystic ovary syndrome	0.0126	0.0322	CcSEcCtD
Reboxetine—Influenza—Metformin—polycystic ovary syndrome	0.0121	0.0308	CcSEcCtD
Reboxetine—Infestation NOS—Metformin—polycystic ovary syndrome	0.0107	0.0275	CcSEcCtD
Reboxetine—Infestation—Metformin—polycystic ovary syndrome	0.0107	0.0275	CcSEcCtD
Reboxetine—Bradycardia—Metformin—polycystic ovary syndrome	0.00982	0.0251	CcSEcCtD
Reboxetine—Rhinitis—Metformin—polycystic ovary syndrome	0.00967	0.0247	CcSEcCtD
Reboxetine—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00948	0.0243	CcSEcCtD
Reboxetine—Eye disorder—Metformin—polycystic ovary syndrome	0.00902	0.0231	CcSEcCtD
Reboxetine—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00896	0.0229	CcSEcCtD
Reboxetine—Angiopathy—Metformin—polycystic ovary syndrome	0.00876	0.0224	CcSEcCtD
Reboxetine—Immune system disorder—Metformin—polycystic ovary syndrome	0.00872	0.0223	CcSEcCtD
Reboxetine—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.0087	0.0222	CcSEcCtD
Reboxetine—Chills—Metformin—polycystic ovary syndrome	0.00866	0.0222	CcSEcCtD
Reboxetine—Malnutrition—Metformin—polycystic ovary syndrome	0.0084	0.0215	CcSEcCtD
Reboxetine—Dysgeusia—Metformin—polycystic ovary syndrome	0.00823	0.021	CcSEcCtD
Reboxetine—Tremor—Metformin—polycystic ovary syndrome	0.00787	0.0201	CcSEcCtD
Reboxetine—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00779	0.0199	CcSEcCtD
Reboxetine—Malaise—Metformin—polycystic ovary syndrome	0.00758	0.0194	CcSEcCtD
Reboxetine—Syncope—Metformin—polycystic ovary syndrome	0.00753	0.0193	CcSEcCtD
Reboxetine—Palpitations—Metformin—polycystic ovary syndrome	0.00742	0.019	CcSEcCtD
Reboxetine—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00738	0.0189	CcSEcCtD
Reboxetine—Hypertension—Metformin—polycystic ovary syndrome	0.00725	0.0186	CcSEcCtD
Reboxetine—Chest pain—Metformin—polycystic ovary syndrome	0.00715	0.0183	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.0071	0.0182	CcSEcCtD
Reboxetine—Discomfort—Metformin—polycystic ovary syndrome	0.00707	0.0181	CcSEcCtD
Reboxetine—Infection—Metformin—polycystic ovary syndrome	0.00681	0.0174	CcSEcCtD
Reboxetine—Shock—Metformin—polycystic ovary syndrome	0.00675	0.0173	CcSEcCtD
Reboxetine—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00672	0.0172	CcSEcCtD
Reboxetine—Skin disorder—Metformin—polycystic ovary syndrome	0.00666	0.017	CcSEcCtD
Reboxetine—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00663	0.017	CcSEcCtD
Reboxetine—Anorexia—Metformin—polycystic ovary syndrome	0.00654	0.0167	CcSEcCtD
Reboxetine—Hypotension—Metformin—polycystic ovary syndrome	0.00641	0.0164	CcSEcCtD
Reboxetine—Paraesthesia—Metformin—polycystic ovary syndrome	0.00616	0.0157	CcSEcCtD
Reboxetine—Dyspnoea—Metformin—polycystic ovary syndrome	0.00611	0.0156	CcSEcCtD
Reboxetine—Somnolence—Metformin—polycystic ovary syndrome	0.0061	0.0156	CcSEcCtD
Reboxetine—Dyspepsia—Metformin—polycystic ovary syndrome	0.00604	0.0154	CcSEcCtD
Reboxetine—Decreased appetite—Metformin—polycystic ovary syndrome	0.00596	0.0152	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00592	0.0151	CcSEcCtD
Reboxetine—Constipation—Metformin—polycystic ovary syndrome	0.00586	0.015	CcSEcCtD
Reboxetine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00565	0.0145	CcSEcCtD
Reboxetine—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00561	0.0143	CcSEcCtD
Reboxetine—Urticaria—Metformin—polycystic ovary syndrome	0.00545	0.0139	CcSEcCtD
Reboxetine—Abdominal pain—Metformin—polycystic ovary syndrome	0.00542	0.0139	CcSEcCtD
Reboxetine—Asthenia—Metformin—polycystic ovary syndrome	0.00492	0.0126	CcSEcCtD
Reboxetine—Diarrhoea—Metformin—polycystic ovary syndrome	0.00469	0.012	CcSEcCtD
Reboxetine—Dizziness—Metformin—polycystic ovary syndrome	0.00453	0.0116	CcSEcCtD
Reboxetine—Vomiting—Metformin—polycystic ovary syndrome	0.00436	0.0112	CcSEcCtD
Reboxetine—Rash—Metformin—polycystic ovary syndrome	0.00432	0.0111	CcSEcCtD
Reboxetine—Dermatitis—Metformin—polycystic ovary syndrome	0.00432	0.011	CcSEcCtD
Reboxetine—Headache—Metformin—polycystic ovary syndrome	0.0043	0.011	CcSEcCtD
Reboxetine—Nausea—Metformin—polycystic ovary syndrome	0.00407	0.0104	CcSEcCtD
Reboxetine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.00123	0.00202	CbGpPWpGaD
Reboxetine—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.00123	0.00202	CbGpPWpGaD
Reboxetine—CYP2D6—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.00123	0.00202	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—SCT—polycystic ovary syndrome	0.00123	0.00201	CbGpPWpGaD
Reboxetine—SLC6A4—Circadian rythm related genes—PPARG—polycystic ovary syndrome	0.00122	0.00201	CbGpPWpGaD
Reboxetine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.00122	0.002	CbGpPWpGaD
Reboxetine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.00118	0.00194	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.00117	0.00192	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.00116	0.00191	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.00116	0.00191	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.00114	0.00188	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.00114	0.00186	CbGpPWpGaD
Reboxetine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.00113	0.00186	CbGpPWpGaD
Reboxetine—CYP2D6—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.0011	0.00181	CbGpPWpGaD
Reboxetine—SLC6A4—Circadian rythm related genes—SERPINE1—polycystic ovary syndrome	0.0011	0.00181	CbGpPWpGaD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.0011	0.0018	CbGpPWpGaD
Reboxetine—CYP2D6—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.00109	0.00179	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.00109	0.00178	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.00106	0.00173	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.00106	0.00173	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.00106	0.00173	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.00104	0.00171	CbGpPWpGaD
Reboxetine—CYP2D6—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.00103	0.00169	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.00103	0.00169	CbGpPWpGaD
Reboxetine—CYP2D6—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00103	0.00168	CbGpPWpGaD
Reboxetine—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—polycystic ovary syndrome	0.00102	0.00167	CbGpPWpGaD
Reboxetine—CYP2D6—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.00101	0.00166	CbGpPWpGaD
Reboxetine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000998	0.00164	CbGpPWpGaD
Reboxetine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000993	0.00163	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.00099	0.00163	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.000987	0.00162	CbGpPWpGaD
Reboxetine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.00098	0.00161	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000958	0.00157	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000942	0.00155	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.00094	0.00154	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000934	0.00153	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000932	0.00153	CbGpPWpGaD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000928	0.00152	CbGpPWpGaD
Reboxetine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000918	0.00151	CbGpPWpGaD
Reboxetine—SLC6A2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000893	0.00147	CbGpPWpGaD
Reboxetine—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000872	0.00143	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000864	0.00142	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000854	0.0014	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.00085	0.0014	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000848	0.00139	CbGpPWpGaD
Reboxetine—SLC6A2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.00083	0.00136	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000814	0.00134	CbGpPWpGaD
Reboxetine—CYP2D6—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000811	0.00133	CbGpPWpGaD
Reboxetine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000805	0.00132	CbGpPWpGaD
Reboxetine—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000803	0.00132	CbGpPWpGaD
Reboxetine—CYP2D6—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.0008	0.00131	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000778	0.00128	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000772	0.00127	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.00077	0.00126	CbGpPWpGaD
Reboxetine—SLC6A2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000759	0.00125	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000749	0.00123	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NPB—polycystic ovary syndrome	0.000747	0.00123	CbGpPWpGaD
Reboxetine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.00074	0.00122	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00074	0.00121	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000723	0.00119	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000721	0.00118	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000715	0.00117	CbGpPWpGaD
Reboxetine—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000711	0.00117	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000706	0.00116	CbGpPWpGaD
Reboxetine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—polycystic ovary syndrome	0.000699	0.00115	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000693	0.00114	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.00068	0.00112	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000675	0.00111	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000672	0.0011	CbGpPWpGaD
Reboxetine—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000671	0.0011	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00067	0.0011	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000663	0.00109	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000661	0.00109	CbGpPWpGaD
Reboxetine—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000661	0.00109	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000657	0.00108	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000656	0.00108	CbGpPWpGaD
Reboxetine—CYP2D6—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000654	0.00107	CbGpPWpGaD
Reboxetine—CYP2D6—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000645	0.00106	CbGpPWpGaD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000642	0.00105	CbGpPWpGaD
Reboxetine—SLC6A2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000637	0.00105	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—SCT—polycystic ovary syndrome	0.00063	0.00103	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000623	0.00102	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000623	0.00102	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—NMNAT3—polycystic ovary syndrome	0.00061	0.001	CbGpPWpGaD
Reboxetine—ABCB1—Allograft Rejection—VEGFA—polycystic ovary syndrome	0.000606	0.000994	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000601	0.000986	CbGpPWpGaD
Reboxetine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.0006	0.000985	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000587	0.000963	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000583	0.000957	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—NMNAT3—polycystic ovary syndrome	0.000575	0.000944	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000566	0.000929	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—LPCAT2—polycystic ovary syndrome	0.000558	0.000916	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—SUOX—polycystic ovary syndrome	0.000558	0.000916	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000551	0.000904	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000537	0.000881	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.00053	0.000871	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	0.000526	0.000864	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	0.000526	0.000864	CbGpPWpGaD
Reboxetine—SLC6A4—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.000524	0.00086	CbGpPWpGaD
Reboxetine—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000523	0.000859	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ISYNA1—polycystic ovary syndrome	0.000519	0.000852	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000501	0.000822	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	0.000489	0.000803	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000488	0.000802	CbGpPWpGaD
Reboxetine—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	0.000488	0.0008	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000458	0.000751	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000456	0.000749	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000447	0.000733	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000444	0.000728	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000441	0.000724	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	0.000441	0.000724	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000429	0.000704	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000428	0.000702	CbGpPWpGaD
Reboxetine—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000422	0.000692	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000417	0.000685	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	0.000416	0.000683	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	0.000416	0.000683	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—FST—polycystic ovary syndrome	0.000407	0.000668	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000404	0.000664	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000402	0.000659	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000399	0.000656	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—LHB—polycystic ovary syndrome	0.000397	0.000652	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000393	0.000645	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000388	0.000637	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000376	0.000617	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000376	0.000617	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000375	0.000616	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—SCT—polycystic ovary syndrome	0.000372	0.000611	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	0.00037	0.000607	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000367	0.000603	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000366	0.0006	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000355	0.000582	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000351	0.000576	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000349	0.000572	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	0.000348	0.000572	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000346	0.000568	CbGpPWpGaD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000344	0.000565	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000344	0.000565	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000344	0.000565	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.00034	0.000559	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—STAR—polycystic ovary syndrome	0.000334	0.000549	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000334	0.000549	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	0.00033	0.000542	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000323	0.00053	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.00032	0.000525	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000319	0.000523	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000318	0.000523	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	0.000315	0.000517	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—INSR—polycystic ovary syndrome	0.000304	0.0005	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000299	0.000491	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	0.000298	0.000489	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000289	0.000475	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000285	0.000467	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000284	0.000467	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PGR—polycystic ovary syndrome	0.000282	0.000463	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	0.000281	0.000461	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000281	0.000461	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000272	0.000446	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000272	0.000446	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	0.000268	0.00044	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000262	0.00043	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000262	0.00043	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—LHB—polycystic ovary syndrome	0.000259	0.000426	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000253	0.000416	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000252	0.000414	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ATF1—polycystic ovary syndrome	0.00025	0.00041	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000245	0.000403	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	0.000244	0.000401	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000244	0.0004	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000243	0.000398	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	0.000239	0.000392	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	0.000231	0.00038	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000231	0.000379	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000229	0.000376	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PRL—polycystic ovary syndrome	0.000229	0.000375	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000228	0.000374	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000226	0.000371	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.00022	0.000362	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	0.000219	0.000359	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000217	0.000356	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	0.000216	0.000355	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	0.000213	0.000349	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	0.000211	0.000346	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	0.000206	0.000338	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	0.000206	0.000338	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	0.000203	0.000333	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000201	0.00033	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	0.0002	0.000329	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	0.000199	0.000326	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000192	0.000315	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	0.000191	0.000313	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000189	0.00031	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	0.000189	0.00031	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000188	0.000309	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000186	0.000305	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	0.000184	0.000301	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	0.000178	0.000292	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	0.000175	0.000288	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	0.000175	0.000288	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000161	0.000264	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—TH—polycystic ovary syndrome	0.000161	0.000264	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	0.00016	0.000262	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—LEP—polycystic ovary syndrome	0.000158	0.000259	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000157	0.000257	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	0.000156	0.000256	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—TH—polycystic ovary syndrome	0.000152	0.000249	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	0.000151	0.000248	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	0.000148	0.000242	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	0.000147	0.000242	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000141	0.000231	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	0.000139	0.000228	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	0.000139	0.000228	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—POMC—polycystic ovary syndrome	0.000135	0.000222	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	0.000135	0.000221	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—INS—polycystic ovary syndrome	0.000135	0.000221	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	0.000131	0.000216	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IGF1—polycystic ovary syndrome	0.00013	0.000214	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—AKT2—polycystic ovary syndrome	0.00013	0.000214	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	0.00013	0.000213	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	0.000125	0.000206	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	0.000125	0.000205	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	0.000124	0.000203	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000124	0.000203	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	0.000123	0.000202	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	0.000119	0.000195	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	0.000118	0.000194	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	0.000116	0.000191	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	0.000115	0.000188	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	0.000112	0.000184	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	0.000111	0.000182	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	0.000104	0.000171	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—IL6—polycystic ovary syndrome	9.96e-05	0.000164	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—TH—polycystic ovary syndrome	9.92e-05	0.000163	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	9.65e-05	0.000158	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	9.07e-05	0.000149	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	8.97e-05	0.000147	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—POMC—polycystic ovary syndrome	8.85e-05	0.000145	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—INS—polycystic ovary syndrome	8.8e-05	0.000144	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.51e-05	0.00014	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	8.45e-05	0.000139	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	8.34e-05	0.000137	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—INS—polycystic ovary syndrome	8.29e-05	0.000136	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	8.1e-05	0.000133	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	7.71e-05	0.000127	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	7.31e-05	0.00012	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	6.82e-05	0.000112	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IL6—polycystic ovary syndrome	5.88e-05	9.66e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	5.53e-05	9.07e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	5.45e-05	8.95e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—INS—polycystic ovary syndrome	5.42e-05	8.9e-05	CbGpPWpGaD
